|
| |
| | | | 1 | | | DO1.PCCNTR.1388161 ContractData Container |
| | | 1.1 | | | | | | | | | | 259,566,100.00 | 0.00 | 0.00 | 0.00 | 257,116,948.40 | 259,566,100.00 |
|
| | | | | | | 5 | | 51111805 - Acetato de gos(...)51111805 - Acetato de goserelina |
| 2.3.4.1.01 | ATEZOLIZUMAB 1200 mg / 20 ml | 90 | UN | 384,000 | 384,000 | 34,560,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 34,560,000.00 | 34,560,000.00 | |
|
| | | | | | | 8 | | 2.3.4.1.01 | BEVACIZUMAB 100 mg / 4 ml | 119 | UN | 23,300 | 24,000 | 2,856,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 2,772,700.00 | 2,856,000.00 | |
|
| | | | | | | 9 | | 2.3.4.1.01 | BEVACIZUMAB 400 mg / 16 ml | 237 | UN | 91,130 | 96,000 | 22,752,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 21,597,810.00 | 22,752,000.00 | |
|
| | | | | | | 11 | | 2.3.4.1.01 | CETUXIMAB 5 mg / ml | 1,040 | UN | 29,500 | 29,500 | 30,680,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 30,680,000.00 | 30,680,000.00 | |
|
| | | | | | | 15 | | 2.3.4.1.01 | DORNASA ALFA 2.5 mg / 2.5 ml | 4,050 | UN | 2,350 | 2,350 | 9,517,500.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 9,517,500.00 | 9,517,500.00 | |
|
| | | | | | | 16 | | 2.3.4.1.01 | EMICIZUMAB 105 mg/ 0.7 ml | 123 | UN | 382,000 | 382,000 | 46,986,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 46,986,000.00 | 46,986,000.00 | |
|
| | | | | | | 17 | | 2.3.4.1.01 | EMICIZUMAB 30 mg/ 1 ml | 186 | UN | 110,000 | 110,000 | 20,460,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 20,460,000.00 | 20,460,000.00 | |
|
| | | | | | | 21 | | 51131802 - Factores antih(...)51131802 - Factores antihemofílicos o globulinas |
| 2.3.4.1.01 | FACTOR IX 500 UI | 150 | UN | 8,850 | 8,800 | 1,320,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 1,327,500.00 | 1,320,000.00 | |
|
| | | | | | | 25 | | 2.3.4.1.01 | INTERFERON BETA 1 a 44 mcg/ 0.5 ml | 4,168 | UN | 16,000 | 16,000 | 66,688,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 66,688,000.00 | 66,688,000.00 | |
|
| | | | | | | 27 | | 2.3.4.1.01 | OBINUTUZUMAB 1000 mg / 40 ml | 62 | UN | 99,800 | 99,800 | 6,187,600.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 6,187,600.00 | 6,187,600.00 | |
|
| | | | | | | 36 | | 2.3.4.1.01 | RITUXIMAB 1400 mg / 11.7 ml | 13 | UN | 86,500 | 86,500 | 1,124,500.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 1,124,500.00 | 1,124,500.00 | |
|
| | | | | | | 41 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TOCILIZUMAB 162mg / 0.9ml | 620 | UN | 11,500 | 11,500 | 7,130,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 7,130,000.00 | 7,130,000.00 | |
|
| | | | | | | 42 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TOCILIZUMAB 80 mg / 4 ml | 833 | UN | 6,900 | 6,900 | 5,747,700.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 5,747,700.00 | 5,747,700.00 | |
|
| | | | | | | 71 | | 51102333 - Hidrocloruro d(...)51102333 - Hidrocloruro de valganciclovir |
| 2.3.4.1.01 | VALGANCICLOVIR CLORHIDRATO 450 MG | 4,560 | UN | 512.64 | 780 | 3,556,800.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 2,337,638.40 | 3,556,800.00 | |
|
|
| | | |
| | | |
|